|
|
Join Catalent at CPhI Discover |
|
|
|
|
Catalent will be exhibiting virtually at CPhI Discover, May 17-28. Join us and take advantage of digital networking and learn more about our capabilities from our world-class team of experts who develop, deliver and supply superior products that improve people’s lives.
Don’t miss our New Product being offered in the New Product Gallery at CPhI Discover. |
|
|
|
|
Catalent provides development and manufacturing services for Dry Powder Inhaler (DPI) capsules. With support for clinical and commercial-scale, the team can handle projects at any stage. Catalent’s Boston-area DPI capsule manufacturing facility is equipped with modern, top-tier encapsulation and blister packaging lines as well as spray driers up to PSD-7-scale.
With over 85 years serving the industry, we have the proven expertise, superior technologies and flexible solutions at the right scale to help ensure successful product development, launch, tech transfer and global reliable supply. Our team of nearly 13,000, including approximately 2,400 scientists at over 35 sites, develops more than 700 projects and helps launch over 200 products every year. |
|
|
|
|
|
Every molecule has a challenge. We have a solution. | | or call +1 877 891 9609 to speak with one of our experts today! | |
|
|
|
|
|
To unsubscribe or manage your subscriptions, please click here. For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at [email protected], or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers. Catalent Pharma Solutions respects your privacy. Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement of the website, its owner(s) or the content. © 2021, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|
|
|
|